ESIL Annual Event: opportunities for Investors and Business Angels

The ESIL Annual Event: Angels and Deeptech – Catalysing Europe’s Innovation Actors (2-3 December 2025) stands as a flagship gathering where visionary business angels, cutting-edge deep tech startups, influential policymakers, and innovation leaders converge to reshape the future of early-stage financing. The event showcases interactive breakout workshops, high-level panel discussions, and exclusive networking opportunities that address Europe's most pressing innovation challenges. Key themes include nurturing the next generation of business angels, developing pan-European investment frameworks, advancing deep tech engagement strategies, and building inclusive innovation ecosystems that drive sustainable growth.

Launching later this year, the ESIL Angel Academy represents Europe's most comprehensive online training program for aspiring and early-stage angel investors. Join the waiting list to be among the first to be informed about its release!

Europe's innovation ecosystem faces a critical inflection point. While startup activity surges across European cities, the continent still lags behind the United States in angel investment and crowdfunding. ESIL addresses this gap by building standardized cross-border frameworks, providing harmonized legal templates, and organising e-pitch events to connect innovators and investors.

Detailed summary of the event

The European Funding Deficit and Macro Ecosystem

Europe maintains a high volume of scientific output, yet Francesca Natali (GreenBone/Angiodroid) observes a persistently low conversion rate into commercial products. To bridge this, Stephane Ouaki (EIC) notes a proposed €34–35 billion EIC budget within a €175 billion Horizon Europe framework — a 3.5x increase. This is bolstered by the Scale-Up Europe Fund, issuing tickets from €30 million to €500 million. However, a structural €1M–€3M "gap" persists for early scale-ups too large for angels but too early for VCs. Denisa Perrin, also from the EIC, highlighted the EIC's comprehensive funding journey — from the Pathfinder to the Accelerator's unique grant-and-equity model — and introduced the new EIC Pre-accelerator, a tool aimed at building a robust applicant pipeline in widening countries.

Deep tech timelines further complicate matters. Claire Munck (BeAngels) identifies an average 15–16 year exit timeline for medtech, conflicting with traditional 10-year VC structures. In response, BeAngels scaled its funds from €2.5M in 2017 to €18M today, with 85% of capital sourced from former entrepreneurs. Historically, public-to-private leverage has proven effective; Sara Dagostini (DG REGIO) reports that ERDF/ESIF instruments achieved a 3.8x multiplier in previous periods.

IP Mechanics and Academic Valorization

University Technology Transfer Offices often hinder investment by demanding high equity or 10% revenue commissions. Marc Van Aken (SO Kwadraat) argues "Fourth-Generation Universities" must cap equity at 2% and limit IP negotiations to 12 weeks, with license fees (0.5%) only triggering after revenues hit 6M CHF (€6.64M). Conversely, Politecnico di Milano takes 0% equity, issuing licenses with zero upfront payments. Under Ivano Ciceri, this model evaluated 1,000 ideas over 16 years, yielding 70 startups and €47M in fundraising.

Early intervention is critical for market transition. Marco Franchin (PHIRE) mandates involving "research angels" at TRL 2 to secure commercial viability. Support structures like the Meta Group’s Booster program have trained 2,000 teams, while SO Kwadraat coached 800 teams, resulting in 246 active Belgian companies. Additionally, the EIC Tech to Market program, reported by Marta Wysoczynska, has already launched 9 startups and embedded 16 external CEOs into research teams.

Syndicate Dynamics and Angel Performance

Standardized frameworks are essential for cross-border liquidity. Reginald Vossen (BAE) and Jenny Tooth (UKBAA) highlight the ESIL framework’s role in creating 7 open-source legal templates vetted across 27 countries. Operational velocity is also a numbers game: Piotr Kedra (PFR Ventures) notes VCs must evaluate 1,000–2,000 transactions annually to succeed. Similarly, Cynthia Verswijvel-Cornelissen (BAN Flanders) reports 600 inbound cases resulting in 25–30 term sheets, utilizing a €1M SPV to ensure diversification.

Individual angel success is mathematically tied to effort. Jörg Stein cites data showing portfolio multiples expand significantly only when due diligence exceeds 20 hours per deal. To manage flow, Jean-Marc Boyer (Global InsurAngels) filters 100 decks to reach 10 investments. In emerging markets, Renata Brkic (Feelsgood Capital) notes a capital vacuum for €50k–€200k needs, while Terezia Jacova (Lumus) dismantles barriers by lowering syndicate tickets to €10k–€20k to attract female investors and subject-matter experts.

Regulatory Barriers and Sector Disruption

Outdated regulations often drain capital faster than R&D. Pierre Cherelle (Axiles Bionics) notes that entering the prosthesis market required a €7.4M Series A in 2023 to bypass 60-year-old medical catalogs. In medtech, Miłosz Jamroży (EFM) warns that MDR standards have extended certification from 3 months to 18 months, forcing "reverse innovation" where companies sell in Asia to survive European delays. Mariana Bozesan (AQAL) advocates for a unified "EU Inc." structure to replace 27-jurisdiction fragmentation.

In high-stakes sectors like space, failure at flight qualification costs 10x more than at TRL 3–5. Stela Tkatchova (EIC) reports €29M deployed for in-space solar projects; notably, EIC selection allows startups like Endurosat to close private rounds of €27M within two months. Institutional backing provides massive leverage, as seen when the EIC’s €30M injection into IQM anchored a €320M Series B. Finally, targeted tech offers compounding yields: Mariana Bozesan notes "Integral Investing" returns 7x multiples, while Stefano Giancola reports Orchestra Scientific’s carbon capture executes at 50% lower cost than competitors.